Jefferson, Temple sign definitive agreement for sale of Fox Chase Cancer Center

Thomas Jefferson University entered into a binding agreement Wednesday with Temple University under which Jefferson will acquire Fox Chase Cancer Center and Temple's bone marrow transplant program. The deal, which will require regulatory approvals, doesn't end there. Jefferson and Temple, which reached a preliminary deal back in July, said they also plan to collaborate in a variety of areas including cancer research and treatment, caring for the underserved, driving innovation, and increasi ng educational…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news

Related Links:

Floyd Rohan Not only do racial and ethnic minority children and adolescents with chronic illness experience disparities in health status and health outcomes, they also experience significant healthcare disparities, including differences in healthcare coverage, access to care, and quality of care. It is well known that the interaction between psychosocial functioning, health behaviors and ethnic and racial disparities, ultimately leads to worse health and psychosocial outcomes in pediatric and AYA chronic illness patient populations, including increased rates of morbidity and mortality. Investigating the impact of ra...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Commentary Source Type: research
The American Society for Transplantation and Cellular Therapy position statement on MMR prevention in immunocompromised cancer and hematopoietic cell transplantation (HCT) patients by Pergam et. al. addresses many of the concerns both providers and patients have about Measles prevention post-transplant.1 However, we are skeptical about the data regarding the safety of the MMR vaccination guidelines for post-allogenic bone marrow transplant patients as stated in this article.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Source Type: research
Innovation in the cancer treatment space offers great promise, but even when approved by the European Medicines Agency (EMA) and other national regulatory bodies, patients can still face protracted delays in accessing new treatments.    Uncertainties in the evidence base for pioneering therapies can lead to delays from health technology assessment (HTA) agencies and payers in securing reimbursement.    To accelerate progress here, HTA frameworks must evolve, says Clare Hague, Therapy Area Market Access Lead, Hematology at Janssen EMEA, speaking ahead of the upcoming eyeforpharma Barcelona 2020 confere...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news
Researchers reveal Adam Castillejo still in remission 12 months after ‘cure’ declaredThe patient who became the second person ever to be cleared of HIV remains free of the virus a year after initial reports of a “cure”, researchers have revealed.Adam Castillejo, who wasuntil Monday known only as the “London patient”,wasdeclared free of HIV last year, 18 months after stopping antiretroviral therapy following a stem cell, or bone marrow, transplant to treat a type of blood cancer.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Aids and HIV Medical research Science London UK news Health Society Source Type: news
Adam Castillejo, 40, was known only as the 'London patient' until today. He was anonymised by doctors who revealed he had been cured of HIV after having a bone marrow transplant for blood cancer.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
This study evaluated the psychometric properties of the Spanish language version of the FACT-BMT in Mexican patients. METHOD: First, the original version was piloted with 15 HSCT patients to obtain an adequate cultural version, resulting in the adaptation of one item. After that, the new version was completed by 139 HSCT patients. RESULTS: The results showed a FACT factor structure that explains 70.84% of the total variance, a factor structure similar to the original FACT structure, and with a high internal consistency (Cronbach's alpha = 0.867). For the BMT subscale, the best factor structure included 17 items w...
Source: Palliative and Supportive Care - Category: Palliative Care Authors: Tags: Palliat Support Care Source Type: research
Abstract PURPOSE: Cytarabine is an effective treatment for AML with associated toxicities including treatment related mortality (TRM). The purpose is to determine the clinical relevance of single-nucleotide polymorphisms (SNPs) identified through the use of HapMap lymphoblastoid cell-based models, in predicting cytarabine response and toxicity in AML. EXPERIMENTAL DESIGN: We tested clinical significance of SNPs associated with cytarabine sensitivity in children with AML treated on Children's Oncology Group regimens (CCG 2941/2961). Endpoints included overall survival (OS), event free survival (EFS) and TRM. P...
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Tags: Clin Cancer Res Source Type: research
Bone Marrow Transplantation, Published online: 02 March 2020; doi:10.1038/s41409-020-0845-1REBOUND “Trained to live again”: The practice of great Olympic coaches improves and enhances the quality of life of cancer patients in remission after hematopoietic stem cell allogeneic transplantation
Source: Bone Marrow Transplantation - Category: Hematology Authors: Source Type: research
The United States Public Health Service Flag Promotion ceremony for Rear Admiral (RADM) Richard W. Childs, promoted to RADM Upper Half O-8 in January 2020, is being webcast live on 3/27/2020 from Masur Auditorium. Richard Childs, MD serves as the Clinical Director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH). He was commissioned in the USPHS Commissioned Corps as a Lieutenant in 1995 when joined the NCI as an Oncology Fellow. Following fellowship training, he was appointed a tenure-track investigator in the Hematology Branch of the NHLBI where he continues to conduct r...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
In conclusion, taller body height at the entry to adulthood, supposed to be a marker of early-life environment, is associated with lower risk of dementia diagnosis later in life. The association persisted when adjusted for educational level and intelligence test scores in young adulthood, suggesting that height is not just acting as an indicator of cognitive reserve. A Comparison of Biological Age Measurement Approaches https://www.fightaging.org/archives/2020/02/a-comparison-of-biological-age-measurement-approaches/ Researchers here assess the performance of a range of approaches to measuring biological...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
More News: Bone Marrow Transplant | Cancer | Cancer & Oncology | Health Management | Pharmaceuticals | Transplants